Evidence based report
Digital transformation of the biopharma supply chain is needed
According to Deloitte analysis from the Deloitte Centre of Health Solutions a research arm of Deloitte’s Life Sciences and Health Care practices. Deloitte Insights “Intelligent drug supply chain” Creating value from AI.
Pharmacist and drug associations want better data
Pharmacists and drug associations want better data on medicine shortages.
Healthcare trends article
Data Analytics Add Value to Healthcare Supply Chain Management
According to Jacqueline LaPointe on August 17, 2018 in RevCycleIntelligence.com. "Data Analytics Add Value to Healthcare Supply Chain Management".
Lockdowns in China around the Eastern Side and Medicine Shortages
As we are aware the majority of EU-approved API manufacturing sites are located in the Eastern side of China areas including Zhejiang, Hubei, Hebei, Shandong and Jiangsu.
Consequences of Drug Shortages
Drug shortages can result from many reasons some of the reasons we have seen include Pandemics, Natural Disasters, Factory shutdowns due to regulatory compliance (self done or externally done),
Political or Policy
Supply chains must move from just in time to just in case: PM
As published in the Australian Financial Review on 8th March 2022, Phillip Coorey. Political editor.
Sandip Manku Article
Medicines Shortages –Reflections from Industry (by Sandip Manku)
In the article, Sandip Manku (Pharmacist and SHPA member) provides his views on Medicine Shortages in Australia from his experiences in dealing with them with his company Pro Pharmaceuticals Group Pty Ltd which since 2015 has been importing medicines from overseas to bridge supply gaps in Australia.
Australian Medicine shortages: Information for sponsors
Sponsors of ‘reportable medicines’ must notify the TGA when the medicine is in shortage or being discontinued.